Efficacy and Safety of Bismuth-Containing Quadruple Therapy for Helicobacter pylori Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg)
Gut 2024 Nov 11;[EPub Ahead of Print], L Olmedo, X Calvet, E Gené, DS Bordin, I Voynovan, M Castro-Fernandez, M Pabón-Carrasco, A Keco-Huerga, Á Perez-Aisa, AJ Lucendo, L Rodrigo, AS Sarsenbaeva, IB Khlinov, G Fadieienko, O Zaytsev, Á Lanas, SJ Martínez-Domínguez, E Alfaro, L Jonaitis, Ó Núñez, R Pellicano, L Hernández, O Gridnyev, J Kupcinskas, A Gasbarrini, D Boltin, Y Niv, G Babayeva, R Marcos-Pinto, B Tepes, M Venerito, V Papp, F Lerang, M Leja, PS Phull, W Marlicz, M Doulberis, SM Smith, V Milivojevic, L Kunovsky, A Mestrovic, T Matysiak-Budnik, H Simsek, A Cano-Català, I Puig, L Moreira, P Parra, OP Nyssen, F Megraud, C O'Morain, JP GisbertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.